HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Cronkhite-Canada Syndrome Associated with Gastric Outlet Obstruction and Membranous Nephropathy: A Case Report and Review of the Literature.

Abstract
A 47-year-old man presented with dysgeusia, anorexia, and diarrhea. An endoscopic evaluation showed widespread gastrointestinal nodular inflammation and polyps. The pathological findings were consistent with Cronkhite-Canada Syndrome (CCS). Prednisolone therapy resulted in clinical improvement. However, CCS relapse complicated with gastric obstruction was observed during drug tapering. Although his symptoms disappeared after the reintroduction of steroids, he developed membranous nephritis. Additional cyclosporine A (CyA) treatment dramatically improved his proteinuria and residual gastrointestinal polyposis. The clinical symptoms resolved with steroid treatment, while CyA was effective for both CCS lesions and membranous nephropathy. CyA might therefore be a potential treatment option for CCS associated with membranous nephropathy.
AuthorsYusuke Onozato, Yu Sasaki, Yasuhiko Abe, Takao Yaoita, Makoto Yagi, Naoko Mizumoto, Masakuni Shoji, Takashi Kon, Takayuki Sakai, Yoshiyuki Ueno
JournalInternal medicine (Tokyo, Japan) (Intern Med) Vol. 59 Issue 22 Pg. 2871-2877 (Nov 15 2020) ISSN: 1349-7235 [Electronic] Japan
PMID32669505 (Publication Type: Case Reports, Journal Article, Review)
Chemical References
  • Prednisolone
Topics
  • Gastric Outlet Obstruction
  • Glomerulonephritis, Membranous (complications, diagnosis, drug therapy)
  • Humans
  • Intestinal Polyposis (complications, diagnosis, drug therapy)
  • Male
  • Middle Aged
  • Neoplasm Recurrence, Local
  • Prednisolone (therapeutic use)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: